Project Grant R01HD115719

Award Date 5/5/25
Completion Date 2/28/30
Dollars Obligated $725K
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award, ID R01HD113567, was provided by the National Institutes of Health (NIH) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $418,194 award, with a project period from August 16, 2024 to May 31, 2029, will support research at Brown University to investigate the developmental and molecular mechanisms underlying the establishment and maintenance of the ovarian follicle reserve. The research aims to better understand,...
The National Institute of Child Health and Human Development (NICHD) awarded a $232,308 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the Magee-Womens Research Institute and Foundation in Pittsburgh, PA. The grant will fund research to elucidate the role of the hyaluronan matrices in establishing and maintaining the ovarian reserve and reproductive longevity, with a focus on understanding the ovarian stromal microenvironment across the...
This $386,855 Project Grant awarded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to King's College London aims to elucidate how follicle-stimulating hormone (FSH) glycoforms modulate the oligomerization and trafficking of the FSH receptor (FSHR) in the aging ovary. The research project will employ advanced imaging, multiomics, and transcriptomic approaches to determine how FSHR oligomerization signatures...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is providing $743,287 to Oregon Health & Science University (OHSU) to conduct a multi-disciplinary research study on endocervical mucus secretion. The goal is to uncover the cellular and pathway mechanisms that regulate mucus properties in response to hormonal changes, with the long-term aim of...
This federal Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to assess the impact of administering the drug romosozumab as an adjunct to physiologic estrogen replacement in adolescents and young adults with functional hypothalamic amenorrhea (FHA). The $1,857,842 award, made on August 6, 2024, will fund a 12-month randomized controlled trial involving...
This $154,000 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to identify and characterize long non-coding RNAs (lncRNAs) that are regulated during the ovulatory process in mouse granulosa cells. The primary goal is to identify the top 5 most highly LH/HCG-regulated lncRNA candidates and investigate their functional role in the ovulatory...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under CFDA program 93.865 Child Health and Human Development Extramural Research, is providing $192,056 to the Magee-Womens Research Institute and Foundation in Pittsburgh, Pennsylvania. The primary objective is to test the feasibility and safety of using adeno-associated virus (AAV) gene therapy to restore fertility in mammalian Sertoli cell dysfunction models. This research aims to...
This is a Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The primary aim of the $1,924,239 award, effective August 1, 2024 through April 30, 2029, is to conduct preclinical drug development studies to create potent, selective, and metabolically stable inhibitors of the serine/threonine kinase 33 (STK33) enzyme as potential first-in-class non-hormonal male...
This federal Project Grant award, with ID R01HD114827, was provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $352,674 award, effective from November 15, 2024 to October 31, 2029, supports research to investigate the molecular mechanisms underlying the development of the terminal nerve, GnRH-1 neuronal migration, and olfactory bulb formation in normal and pathological...
This $760,617 federal Project Grant award was provided by the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to The Children's Hospital Corporation (doing business as Boston Children's Hospital). The grant supports research to identify key transcription factors and dissect the mechanisms underlying the transitions between pre-pluripotent, naive, and formative pluripotent states in the inner...

The federal Project Grant award R01HD115719, totaling $724,714, was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The purpose of this 5-year grant is to evaluate the effects of exogenous anti-Müllerian hormone (AMH) on ovarian function and fertility in non-human primates. Specifically, the research aims to: 1) determine if supraphysiological AMH can induce contraception without disrupting estradiol homeostasis, 2) assess if AMH can reduce the rate of ovarian aging by modulating follicle dynamics, and 3) examine whether chronic AMH treatment affects oocyte and embryo quality. This grant will provide critical insights into the mechanisms of action of AMH in regulating female fertility, with the potential to develop novel AMH-based treatments for contraception, ovarian aging, and fertility enhancement. The awardee, The General Hospital Corporation (doing business as Massachusetts General Hospital), is a renowned nonprofit academic medical center and major recipient of federal research funding, leveraging its extensive research capabilities to conduct this innovative reproductive biology study.

Generated 6/17/25, 4:51 AM